Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Auswellife Royal Jelly 2180 - TGA Drug Approval Details

Approvals/TGA/Auswellife Royal Jelly 2180

Approved

STANDARD

Auswellife Royal Jelly 2180

Aussia Pharma🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: dfc4e4078e5abc39
Company: Aussia Pharma
Type: Standard

Approval Details

Approval Id: dfc4e4078e5abc39
Product Name: Auswellife Royal Jelly 2180
Artg Id: 287830
Artg Name: Auswelllife Royal Jelly 2180
Sponsor: Aussia Pharma
Company Detail Path: /organization/aussia-pharma-oem-services-pty-ltd
Artg Date: 2017-04-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

dfc4e4078e5abc39

Type

Standard

Back to TGA Approvals